Viewing Study NCT01998035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-03-06 @ 1:13 PM
Study NCT ID: NCT01998035
Status: TERMINATED
Last Update Posted: 2024-08-22
First Post: 2013-11-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
Sponsor: Columbia University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoid Malignancies View
None Lymphoma View
None Hodgkin Lymphoma View
None Non-hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoid Malignancies View
None Lymphoma View
None Hodgkin Lymphoma View
None Non-hodgkin Lymphoma View
None Follicular Lymphoma View
None Diffuse Large B-Cell Lymphoma View
None Anaplastic Large Cell Lymphoma View
None Chronic Lymphocytic Leukemia View
None Small Lymphocytic Lymphoma View
None Mantle Cell Lymphoma View
None Marginal Zone Lymphoma View
None Burkitt Lymphoma View
None Waldenstrom Macroglobulinemia View
None Peripheral T-cell Lymphoma View
None Cutaneous T-cell Lymphoma View